Ipra
COMPOSITION
Each mL Contains:
0.6 mg of ipratropium bromide anhydrous basis (42 mcg/spray).
INDICATIONS
Ipratropium bromide nasal solution, 0.06% is indicated for the symptomatic relief of rhinorrhea associated with the common cold or seasonal allergic rhinitis for adults and children age 5 years and older. Ipratropium bromide nasal solution, 0.06% does not relieve nasal congestion or sneezing associated with the common cold or seasonal allergic rhinitis.
The safety and effectiveness of the use of ipratropium bromide nasal solution, 0.06% beyond four days in patients with the common cold or beyond three weeks in patients with seasonal allergic rhinitis has not been established.
Ipratropium Bromide Nasal Solution 0.03% (Nasal Spray) is indicated for the symptomatic relief of rhinorrhea associated with allergic and nonallergic perennial rhinitis in adults and children age 6 years and older. Ipratropium Bromide Nasal Solution 0.03% (Nasal Spray) does not relieve nasal congestion, sneezing, or postnasal drip associated with allergic or nonallergic perennial rhinitis.
DOSAGE AND ADMINISTRATION
IPRATROPIUM (0.06%)
For Symptomatic Relief of Rhinorrhea Associated with the Common Cold
The recommended dose is two sprays (84 mcg) per nostril three or four times daily (total dose 504 to 672 mcg/day) in adults and children age 12 years and older. Optimum dosage varies with response of the individual patient. The recommended dose of ipratropium bromide nasal solution, 0.06% for children age 5 to11 years is two sprays (84 mcg) per nostril three times daily (total dose of 504 mcg/day).
The safety and effectiveness of the use beyond four days in patients with the common cold have not been established.
For Symptomatic Relief of Rhinorrhea Associated with Seasonal Allergic Rhinitis
The recommended dose is two sprays (84 mcg) per nostril four times daily (total dose 672 mcg/day) in adults and children age 5 years and older.
The safety and effectiveness of the use beyond three weeks in patients with seasonal allergic rhinitis have not been established.
IPRATROPIUM (0.03%)
The recommended dose is two sprays (42 mcg) per nostril two or three times daily (total dose 168 to 252 mcg/day) for the symptomatic relief of rhinorrhea associated with allergic and nonallergic perennial rhinitis in adults and children age 6 years and older. Optimum dosage varies with the response of the individual patient.
Initial pump priming requires seven sprays of the pump. If used regularly as recommended, no further priming is required. If not used for more than 24 hours, the pump will require two sprays, or if not used for more than seven days, the pump will require seven sprays to reprime.
HOW SUPPLIED:
Ipra Fort :A glass bottle with a plastic nasal spray, containing 15 ml (180 sprays) at a concentration of 0.03% in a carton box..